Melanin Inhibitor (8,000 mg) Minimizes dark spots by regulating melanin production
Sleep and circadian restoration Researchers specifically targeting sleep improvement might emphasize bedtime administration and potentially start with lower doses to assess individual sensitivity to melatonin-related effects
Epithalon is dispensed as 50 mg vials
Modifier 59, Distinct Procedural Service, would be appended to the second and any subsequent injection codes listed on the claim form
By Product: Ozempic dominates, Tirzepatide products growing fastest Ozempic (semaglutide 0.5mg/1mg/2mg weekly subcutaneous injection) dominated the GLP-1 receptor agonist market with approximately 35.12% market share in 2025, driven by its combination of robust clinical efficacy data, early market entry, broad diabetes label, established prescriber relationships, and expanded off-label use for weight management before Wegovy's commercial scale-up